🧫
TLR4-NF-κB-NLRP3 Axis Inhibition in iPSC-derived Microglia for AD Prevention
active
experiment
Created: 2026-04-26T06:56:03
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-e0fb9d27d97e
🧫 Experiment Protocol
In-VitroAlzheimer diseaseiPSC-derived microglia-neuron co-culture from AD patientsproposed
Evaluate whether selective TLR4-NF-κB-NLRP3 axis inhibition reduces neuroinflammatory burden and prevents neuronal loss in Alzheimer disease iPSC-derived microglia-neuron co-culture models.
PRIMARY OUTCOME
NLRP3 inflammasome activation markers (IL-1β, IL-18) and neuronal viability (TUNEL/cleaved caspase-3)
EXPECTED OUTCOMES
Reduction in NLRP3 inflammasome activation (IL-1β, IL-18 release) by >50% and decreased neuronal apoptosis in co-culture.
SUCCESS CRITERIA
NLRP3 activation assay (ELISA) + TUNEL staining neuronal viability; threshold: p < 0.05 vs. LPS-stimulated control.
PROTOCOL
in-vitro
Source: auto-generated
🧫 Experiment Extras
ESTIMATED COST
$45,000
TIMELINE
8 months
MARKET PRICE
$0.50
STATUS
proposed
Scoring Dimensions
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.